869489-00-9 Usage
Uses
Used in Organic Synthesis:
(2S,4S)-1-Boc-2-(3,3-difluoropyrrolidine-1-carbonyl)-4-(1-piperazinyl)pyrrolidine is used as a building block for the synthesis of various organic compounds. The Boc protecting group allows for selective reactions to occur at other sites on the molecule, facilitating the construction of complex organic structures.
Used in Pharmaceutical Applications:
(2S,4S)-1-Boc-2-(3,3-difluoropyrrolidine-1-carbonyl)-4-(1-piperazinyl)pyrrolidine is used as a potential candidate in drug discovery and development. The difluoropyrrolidine-1-carbonyl and piperazinyl groups may contribute to its pharmacological properties, making it a promising compound for the development of new therapeutic agents.
Used in Drug Discovery:
In the pharmaceutical industry, (2S,4S)-1-Boc-2-(3,3-difluoropyrrolidine-1-carbonyl)-4-(1-piperazinyl)pyrrolidine is used as a lead compound for the identification of novel drug targets. Its unique structure and functional groups provide a foundation for the design and optimization of new drugs with improved efficacy and selectivity.
Used in Medicinal Chemistry:
(2S,4S)-1-Boc-2-(3,3-difluoropyrrolidine-1-carbonyl)-4-(1-piperazinyl)pyrrolidine is utilized in medicinal chemistry as a template for the development of new chemical entities. Its structural features can be modified to explore structure-activity relationships and optimize the compound's pharmacological properties for specific therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 869489-00-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,9,4,8 and 9 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 869489-00:
(8*8)+(7*6)+(6*9)+(5*4)+(4*8)+(3*9)+(2*0)+(1*0)=239
239 % 10 = 9
So 869489-00-9 is a valid CAS Registry Number.
869489-00-9Relevant academic research and scientific papers
Therapeutic compounds
-
Page/Page column 13, (2008/06/13)
The invention provides compounds of formula (I), prodrugs and stereoisomers thereof, and the pharmaceutically acceptable salts of the compounds, prodrugs, and stereoisomers, wherein R1, R2, R3, HET, n, Q, X, Y, and Z are as described herein; compositions thereof; and uses thereof in treating diabetic complications including diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy, and the like.
